Canada's
Premier Portuguese Directory
What is Opsoclonus Myoclonus ?
Opsoclonus myoclonus is a rare neurological disorder characterized by unsteady gait, intention tremor (rhythmic, involuntary motions of the limbs during voluntary movements), myoclonus (brief, shock-like muscle spasms), and opsoclonus (irregular, rapid, horizontal and vertical eye movements). Other symptoms may include dysphasia (difficulty speak), dysarthria (poorly articulated speech), mutism (inability to speak), hypotonia (decreased muscle tone), lethargy, irritability, or malaise (a vague feeling of bodily discomfort). Opsoclonus myoclonus may occur in association with tumors or viral infections.
Is there any treatment ?
Treatment for opsoclonus myoclonus may include corticosteroids or ACTH (adrenocorticotropic hormone). In cases where there is a tumor present, treatment such as chemotherapy, surgery, or radiation may be required.
What is the prognosis?
The prognosis for opsoclonus myoclonus varies depending on the symptoms and the presence and treatment of tumors. With treatment of the underlying cause of the disorder, there may be an improvement of symptoms. Spontaneous remissions (unexplained lack of disease activity) may also occur. Generally the disorder is not fatal.
What research is being done?
National Pediatric Myoclonus Center (NPMC)
The purpose of a national center for myoclonus is to provide the best care possible for patients whose myoclonus
began during childhood. This care includes making the correct diagnosis,
searching for all reversible (curable) causes, choosing the best drug treatments
available, providing information about myoclonus, obtaining psychological and
emotional support for the children and their families, and bringing them
together with other similar families. We also wish to establish the scope of the
problem and increase awareness among federal, private and pharmaceutical
agencies. Patients with myoclonus otherwise have no advocate. They are often
misdiagnosed, told there is no hope, feel isolated, and are in need of a
concerted effort to better their situation.
The NINDS supports and conducts research on movement disorders such as
opsoclonus myoclonus. Current research is attempting to clarify and expand the
knowledge about movement disorders, and to find ways to prevent and treat
these disorders.
OMS was first described by Dr. M. Kinsbourne in 1962.
Other names for OMS include:
* Opsoclonus Myoclonus Syndrome (OMS)
* O.M.S
* Opsoclonus Myoclonus Ataxia (OMA)
* Kinsbourne syndrome
* Myoclonic Encephalopathy of infants
* Dancing Eyes-Dancing Feet syndrome
* Dancing Eyes syndrome
First signs of OMS
Symptons after being
diagnosed/treated for OMS
tumor or viral. (OMS FACTS)